 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
1 News |  |
- || Qingshu-Yiqi-Tang / Chuang Song Zong Pharma
New P2/3 trial, Metastases: QSYQT: Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients (clinicaltrials.gov) - Feb 27, 2013
P2/3, N=120, Recruiting, Sponsor: Chang Gung Memorial Hospital